AOB Pharma Partners Biorasi for Phase 2b Acne Trial
CAMBRIDGE, Mass., July 1, 2026 AOB Pharma has entered into a strategic partnership with global clinical research organization Biorasi...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAMBRIDGE, Mass., July 1, 2026 AOB Pharma has entered into a strategic partnership with global clinical research organization Biorasi...
NORTH CHICAGO, Ill. | July 1, 2026 Rosalind Franklin University of Medicine and Science (RFU) has showcased groundbreaking advances...
MILWAUKEE, Feb. 14, 2026 — New research presented at the AAAAI Annual Meeting 2026 demonstrates that machine learning (ML)...
AliveDx, a global in-vitro diagnostics innovator, today announced it has submitted a 510(k) premarket notification to the U.S. Food...
